Sangamo Therapeutics SGMO Q1 2026 Results Fall Short EPS 008 Revenue NA Enliven Therapeutics ELVN Delivers Q1 2026 Beat EPS 038 vs 047 Expected Armada Secures 230M at 2B Valuation Partners With Johnson Controls for Arizona Factory Nvidia to Establish Singapore Research Hub as CityState Accelerates AI Initiatives